Rationale: Ca 2؉ control of troponin-tropomyosin position on actin regulates cardiac muscle contraction. The inhibitory subunit of troponin, cardiac troponin (cTn)I is primarily responsible for maintaining a tropomyosin conformation that prevents crossbridge cycling. Despite extensive characterization of cTnI, the precise role of its C-terminal domain (residues 193 to 210) is unclear. Mutations within this region are associated with restrictive cardiomyopathy, and C-terminal deletion of cTnI, in some species, has been associated with myocardial stunning. Objective: We sought to investigate the effect of a cTnI deletion-removal of 17 amino acids from the C terminuson the structure of troponin-regulated tropomyosin bound to actin. Methods and Results: A truncated form of human cTnI (cTnI 1-192 ) was expressed and reconstituted with troponin C and troponin T to form a mutant troponin. Using electron microscopy and 3D image reconstruction, we show that the mutant troponin perturbs the positional equilibrium dynamics of tropomyosin in the presence of Ca 2؉ . Specifically, it biases tropomyosin position toward an "enhanced C-state" that exposes more of the myosinbinding site on actin than found with wild-type troponin. Conclusions: In addition to its well-established role of promoting the so-called "blocked-state" or "B-state," cTnI participates in proper stabilization of tropomyosin in the "Ca 2؉ -activated state" or "C-state." The last 17 amino acids perform this stabilizing role. The data are consistent with a "fly-casting" model in which the mobile C terminus of cTnI ensures proper conformational switching of troponin-tropomyosin. Loss of actin-sensing function within this domain, by pathological proteolysis or cardiomyopathic mutation, may be sufficient to perturb tropomyosin conformation. (Circ Res. 2010;106:705-711.) Sample B-State (%) C-State (%) Enhanced C-State (%) Ca 2ϩ -treated filaments with wild-type troponin 29 43 28 Ca 2ϩ -treated filaments with mutant troponin 26 17 57 708 Circulation
L esions of the myofilament proteins are a common cause of inherited and acquired forms of heart disease. 1, 2 Such defects in the thin filament protein, cardiac troponin (cTn)I, have been implicated in both hypertrophic and restrictive cardiomyopathy, as well myocardial stunning. For example, mutations within the C-terminal domain of the cTnI gene that cause amino acid substitutions R192H, G203S, and K206Q lead to hypertrophic and/or restrictive cardiomyopathy, 3, 4 whereas removal of the C-terminal 17 amino acids from cTnI by Ca 2ϩ -dependent proteolysis has been implicated in models of myocardial stunning, [5] [6] [7] [8] [9] a condition that arises from brief ischemia that substantially depresses contractile function without causing cell death. 2, 10 In fact, expression of truncated cTnI , at levels Ͻ20% relative to endogenous cTnI, is sufficient to substantially compromise systolic and diastolic function 11 in mice. Moreover, C-terminal degradation of cTnI has been observed in patients undergoing coronary artery bypass graft surgery. 12 Given the role of this domain of cTnI in genetic and acquired heart disease, efforts are underway to fully understand its function.
TnI is 1 of the 3 subunits that comprise the troponin complex that regulates muscle contraction by controlling the position of tropomyosin on actin filaments in response to Ca 2ϩ . 13, 14 Known as the inhibitory subunit of troponin, it prevents myosin binding to actin, in diastole, by maintaining tropomyosin over the outer edge of actin filaments. In systole, Ca 2ϩ binds to the Ca 2ϩreceptor subunit of troponin, TnC, which causes a conformational change that promotes its interaction with cTnI and coincident release of TnI inhibitor regions from actin. In turn, this causes the average position of tropomyosin to shift across the face of actin and thereby exposes myosin-binding sites that are then accessible for myosin to begin crossbridge cycling. 15 The domains of TnI, which contain multiple binding sites for TnC, TnT, actin, and tropomyosin, have been extensively characterized, 16 and their organization has been clarified by the low-and high-Ca 2ϩ crystal structures of cardiac and skeletal muscle troponin. 17, 18 However, only an incomplete picture of the regulatory switching of tropomyosin on actin can be garnered from the troponin structures, because the C terminus of TnI is unresolved, owing to its high flexibility. 19 Given the pathological significance of lesions with the C terminus of cTnI, we sought to determine how truncation of TnI affects the prime function of troponin, namely, its ability to modulate tropomyosin position on actin filaments. We discuss newly acquired structural data in the context of recent biochemical and biophysical studies of cTnI and a newly proposed model of cTnI function. 20
Methods

Protein Preparation
F-Actin and bovine cardiac tropomyosin were purified by standard methods. 21 Methods describing the expression, purification, and reconstitution of troponin subunits are described in the Online Data Supplement, available at http://circres.ahajournals.org.
Electron Microscopy
Thin filaments were reconstituted by mixing actin, tropomyosin, and wild-type or mutant troponin in a ratio of 7:2:2 (F-actin: 10 to 20 mol/L) in both low-and high-calcium buffers (low Ca 2ϩ : 5 mmol/L PIPES/5 mmol/L sodium phosphate buffer [pH 7.1], 100 mmol/L NaCl, 3 mmol/L MgCl 2 , 0.2 mmol/L EGTA, 1 mmol/L NaN 3 , 1 mmol/L DTT; high-Ca 2ϩ : same buffer supplemented with 2 mmol/L CaCl 2 ). Uranyl acetate staining is described in the Online Data Supplement. Electron microscopy was carried out on a Philips CM120 transmission electron microscope using low-dose methods (12 e Ϫ /Å), the details of which are described elsewhere. [22] [23] [24] 
Three-Dimensional Image Reconstruction From Electron Micrographs
Electron micrographs were digitized and analyzed by 2 distinct yet complementary methods of image reconstruction. 22, 23 First, data were analyzed by helical reconstruction, a Fourier-space filtering and averaging method, using the Brandeis Helical Package essentially as detailed in. 23 Given the subtle, yet statistically and biologically significant, changes that we observed in thin filament structure, the results were cross-validated by further analysis of micrographs from an independent protein preparation using the real-space singleparticle averaging method of Egelman, 25 as described by Pirani et al. 22 (For a comparison of results obtained from both reconstruction methods, see Figure III in the Online Data Supplement at http://circres.ahajournals.org.)
Results
Electron Microscopy and Three-Dimensional Reconstruction of Wild-Type and cTnI 1-192 -Containing Thin Filaments
Thin filaments were formed from F-actin, cardiac tropomyosin and troponin complexes under conditions known to saturate the filaments with regulatory proteins. [22] [23] [24] "Wildtype" and mutant troponin complexes, reconstituted from subunits expressed in Escherichia coli, were used for comparison. The mutant troponin contained a truncated form of cTnI (cTnI ) but included otherwise normal troponin subunits, human cTnC and cTnT. Filaments were negatively stained in uranyl acetate and recorded by low-dose electron microscopy. 23 Electron microscopy (EM) of the thin filaments showed characteristic double-helical arrays of actin monomers, tropomyosin strands, and troponin densities repeating with a 40 nm periodicity ( Figure 1 ). EM images of reconstituted filaments prepared from separately expressed and purified proteins were analyzed independently by the first and last authors; the raw images and 3D reconstructions generated from the 2 data sets were indistinguishable from each other and thus combined for analysis here. Filaments were studied by both helical reconstruction of relatively long filament stretches (Ϸ200 to 400 nm) 26 and by single-particle methods on filament segments (Ϸ40 nm) 25 ; results from the 2 methods were completely consistent and reproducible.
Reconstructions of thin filaments showed actin subunits and densities that were attributable to tropomyosin ( Figure 2 ). The longitudinally continuous tropomyosin strands were well defined in both control filaments containing "wild-type" troponin- tropomyosin and in filaments containing the mutant cTnI . Inspection of the reconstructions showed that the mutation did not interfere with the ability of tropomyosin to undergo a Ca 2ϩ -induced shift from the outer domain (A o ) to the inner domain (A i ) of actin; thus, the impact of both the wild-type troponin and mutant troponin on directed tropomyosin movement is normal in both sets of filaments. In fact, in high-Ca 2ϩ conditions, tropomyosin localized further onto A i in filaments containing mutant cTnI (Figures 2c and 3c) than it did in filaments with the wild-type TnI (Figures 2b and 3b ). Thus, whereas the direction of the tropomyosin movement was the same in both samples, the magnitude of the movement was greater in the mutant (superimposed in Figure 2d and Figure 3d ). As a consequence, in high Ca 2ϩ , less lingering density touched A o in the mutant filaments than in the wild-type. In contrast, no obvious differences in tropomyosin position on F-actin were found for the low Ca 2ϩ data (Figures 2g and 3g ).
At Hight Ca 2؉ , the Effect of cTnI 1-192 Is Statistically Significant
Helical projection, ie, projection of densities down the helical axis of F-actin and tropomyosin, provides a means of defining the average position of tropomyosin relative to actin in reconstructions. Comparison of helical projections confirmed that tropomyosin is localized differently in wild-type and mutant thin filaments, but again such a distinction was only detected for the high Ca 2ϩ -treated sample. The distinction was subtle but became obvious following difference density analysis that isolated 
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the respective tropomyosin densities from actin. Here, maps of F-actin (no tropomyosin) were simply subtracted from those of thin filaments. The resulting tropomyosin densities then were superimposed on reference maps of bare F-actin and compared ( Figure 4e ). In the presence of Ca 2ϩ , tropomyosin controlled by mutant troponin was shifted azimuthally by about 9°more than it was by wild-type troponin (Figure 4e ). Point by point analysis of the maps using Student t test methodology 27, 28 showed that this difference in tropomyosin position was statistically significant at 95% confidence levels. (Also see Online Figure IV , which demonstrates further that the distinctions noted are statistically significant.) Because the average position of tropomyosin in the mutant is further from the low Ca 2ϩ , blocking state than it is in control filaments, we call it the "enhanced C-state." Differences in tropomyosin positions for low-Ca 2ϩ filaments were not obvious or statistically significant.
Tropomyosin Equilibrium Position on Thin Filaments Is Altered by cTnI 1-192
Tropomyosin is thought to oscillate laterally over a narrow region of the flat surface of actin 22, 29 ; however, in the presence of troponin, its equilibrium balance becomes more biased toward specific regulatory positions on actin, 24, 30, 31 namely, those of the low-Ca 2ϩ B-state or the high-Ca 2ϩ C-state. The results above suggest that the mutant caused a rebalancing between positional states or possible development of a new equilibrium position for tropomyosin. Cross-correlation tools 32, 33 comparing the experimental data to thin filament models with different tropomyosin locations were used to sort and classify short filament segments into positional categories. An analysis of high Ca 2ϩ filaments indicated that Ϸ3.5 times more mutant filament data fitted better to the "enhanced C-state" than to the wild-type C-state position, whereas the reverse was true for wild-type data, where more of the data belonged to the C-state category (Table) .
Discussion
Control of Tropomyosin Conformation by TnI 1-192
The C-terminal half of cTnI harbors 3 well-characterized domains: (1) an actin-binding region that inhibits actomyosin ATPase activity (inhibitory peptide; residues 128 to 147); (2) a region that binds to the N-terminal domain of troponin C in the presence of Ca 2ϩ (switch peptide; residues 148 to 163);
and (3) a second actin-binding site (residues 168 to 188). The function of the remaining C-terminal residues (residues 189 to 210) is largely unknown. In the absence of Ca 2ϩ , this highly flexible domain 19 adopts a more defined structure as it binds to actin. Image reconstruction of thin filaments saturated with the C-terminal half of TnI show that the inhibitory region binds to actin at its N terminus (subdomain 1). Residues downstream of the inhibitory peptide span the cleft of the long-pitch helical actin strands, much like the smooth muscle inhibitory protein caldesmon, 34 and drape over subdomains 3 and 4 of the adjacent actin, where they abut tropomyosin and stabilize it in the blocked state (B-state). 31 The human cTnI construct, like the form that recapitulates the phenotype of myocardial stunning in mice, 11 lacks the last 17 amino acids. Previous biochemical studies 35 showed that cTnI , alone, bound both actin and actin-tropomyosin with the same affinity as full length cTnI. Yet when cTnI was reconstituted into troponin, the complex could not fully inhibit ATPase activity in the absence of Ca 2ϩ . This suggested that either cTnI could not maintain tropomyosin in a fully competent B-state or that equilibrium dynamics between the B-and C-states of the thin filament of might be altered. As shown in Figures 2g and 3g , mutant troponin caused no statistically discernible difference in the average position of tropomyosin in the presence of EGTA. Thus, residues 193 to 210 of cTnI, downstream of its major actin-binding regions, are not required to generate the B-state position of tropomyosin.
In the presence of Ca 2ϩ , the mutant troponin displays higher maximal Ca 2ϩactivated actin-tropomyosin-S1 ATPase than does the wild-type troponin. 35, 36 Similar observations of both higher basal and Ca 2ϩ -activated ATPase activity 35 were noted in studies of the murine variant of restrictive cardiomyopathy is also responsive to Ca 2ϩ and tropomyosin again adopts and average position over the inner domain of actin. d, Superimposing results from b and c shows that tropomyosin, controlled by mutant troponin, has shifted azimuthally to adopt an average position further from the outer actin domain by about 9°. e, To better visualize the image densities arising from the tropomyosin strands, the image density of bare actin filaments was subtracted from b and c. The densities of tropomyosin controlled by wild-type (light green) or mutant troponin (dark green) were superimposed over the helical projection of bare actin (blue). The difference in the centroid positions of tropomyosin density were statistically significant at Ͼ95%.
Table. Distribution of Filament Segments Sorting to Different Regulatory States
mutant, R193H. 37 Wild-type troponin could confer comparable maximal activity, provided that thin filaments were fully activated by noncycling NEM-S1 heads. The data could be best explained by a shift in the tropomyosin equilibrium from the inactive to the active state 37 or, in the context of a 3-state structural model, a shift that would favor transition to the myosin-induced state (M-state). Here, incorporation of cTnI into troponin, in the presence of Ca 2ϩ , evinces a tropomyosin position shifted further over the inner domain of actin (ie, subdomains 3 and 4) than typically observed with wt troponin in Ca 2ϩ . The 9°azimuthal shift of tropomyosin, although subtle, is most easily discernible in the cross section of the filament (Figure 3d ) and the helical projection (Figure 4e ). The displacement is approximately half of the width of tropomyosin and just shy of the fully activated M-state observed in the presence of Ca 2ϩ and docked myosin-S1 heads.
Note that the average position of tropomyosin is a function of the frequency with which one regulatory configuration or another is adopted, ie, the "enhanced C-state" is not a fixed position on actin but rather is associated with a readjusted distribution of positional states (Table) . Tropomyosin regulated by wild-type troponin can also adopt the enhanced C-state, albeit less frequently, ie, in 28% of wild-type filaments versus 57% among mutant filaments. Therefore, the position of tropomyosin defined by mutant troponin is not a new structural state, per se, but rather a perturbation of the natural equilibrium distribution of tropomyosin on actin. This increases the propensity for tropomyosin to be found further over the inner domain of actin that is comprised of subdomains 3 and 4. Hence, actin can more easily bind myosin crossbridges.
The data in Figures 2d, 3d , and 4e are the first to depict alterations of thin filament structure by a pathological lesion of troponin, and they provide insight into how cTnI , alters the Ca 2ϩ sensitivity of myofilaments. Specifically, we and others have shown that cTnI increases the Ca 2ϩ sensitivity of the ATPase reaction, 35, 36 and cTnI incorporation into rat trabeculae and human cardiomyocytes increases the Ca 2ϩ sensitivity of steady-state isometric tension. 36, 46 To determine the mechanism, Tachampa et al 36 measured the effect of the mutant on Ca 2ϩ affinity for TnC within the troponin complex. Although isolated troponin showed no difference, Ca 2ϩ affinity was increased when mutant troponin was bound to thin filaments. 36 However, myofilament Ca 2ϩ sensitivity also reflects the degree to which Ca 2ϩ -binding would ultimately affect tropomyosin movement. The primary novel finding of this study is that Ca 2ϩ binding to mutant troponin shifts the average position of tropomyosin, not to the normal C-state, but to a state that more closely resembles myosin-induced M-state over subdomain 3 and 4 of actin, thereby exposing more of the myosin binding site on actin. Thus, the integrity of the C terminus of TnI appears to mediate proper equilibrium transitions between the B-, C-, and near-Mstates, and its effect can only be observed properly in the context of the entire thin filament.
Intact cTnI is therefore necessary for stabilization of the natural C-state of tropomyosin on actin, in addition to its established role as stabilizer the B-state in the absence of Ca 2ϩ . Ca 2ϩ -activation of the thin filament is widely held to involve removal of cTnI from actin as the switch peptide of cTnI (residues 148 to 163) binds to the N-terminal domain of TnC.
However, simple removal of cTnI inhibition in Ca 2ϩ , and release of the B-state, is inconsistent with recent biochemical studies showing that cardiomyopathy mutations within distinct C-terminal domains of cTnI perturb tropomyosin equilibrium differently. 37, 38 Whereas some mutations, notably within the inhibitory peptide, appear to exhibit B-state defects, others closer to the C terminus are more consistent with defects of the C-state. Moreover, in vitro motility analysis has shown that the sliding velocity of thin filaments regulated by TnI G203S and TnI K206Q was Ca 2ϩ -sensitized and ultimately higher in maximum Ca 2ϩ , indicative of greater thin filament activation. 39 Therefore, lesions within the last 17 amino acids of cTnI may cause aberrant thin filament activation by destabilizing the C-state of tropomyosin in favor of a conformation that more closely resembles the fully active M-state.
Proposed Mechanism of C-State Stabilization by the C Terminus of cTnI
If cTnI is an active participant in C-state stabilization, the salient question is, how. Recently, an innovative "fly-casting" hypothesis has been proposed 20 to describe the manner by which the highly-disordered C-terminal region of cTnI might contribute to muscle regulation. When Ca 2ϩ binds to the N-terminal lobe of TnC, and the TnC-binding switch peptide of cTnI binds the hydrophobic pocket of TnC, the TnI inhibitory peptide and second actin-binding domain are removed from actin in the process. However, the fly-casting hypothesis posits that residues that lie C-terminal to the TnI switch peptide (the mobile domain) would continue to participate in long-range sampling, or sensing, of the thin filament via transient ionic interactions. This would effectively catalyze TnI binding to actin when Ca 2ϩ dissociates from TnC. 19, 20 If these weak interactions between the mobile domain of cTnI and actin destabilize binding of the switch peptide to the N-terminal domain of TnC, 20 then C-terminal deletions of thin filament-bound cTnI would, conversely, confer higher affinity for TnC. Indeed, we noted this previously, as cTnI -mediated inhibition of actin-tropomyosinactivated ATPase was more easily reversed by TnC in the presence of Ca 2ϩ (see Foster et al 35 and figure 3B therein) .
From the perspective of the fly-casting model, cTnI is deficient in 2 ways. It lacks the last 17 amino acids and therefore casts a shorter "fishing line" with which to "sense" actin. It also lacks 4 basic residues, 3 lysines and 1 arginine. Because Lys and Arg are critical determinants of actinbinding affinity in the inhibitory region 40 and second actinbinding sites of TnI, 41 these residues in the C terminus of cTnI may also interact weakly/transiently with Asp and Glu residues on the actin filament. These weak cTnI-actin interactions could well be sufficient to stabilize tropomyosin in a wild-type C-state, given the correspondingly low local affinity of tropomyosin for F-actin. 42 We suspect that pathophysiological changes to the C terminus of TnI that abrogate its transient ionic interactions with actin, or impinge on its flexibility, may destabilize the C-state and thereby favor movement of troponin-tropomyosin to an enhanced-C-state. Biochemical studies have shown that cardiomyopathies arising from cTnI mutations alter the equilibrium positions of tropomyosin 37, 38 and lesions within the C terminus, D190H R192H, G203S, and R206Q likewise exert Ca 2ϩ -sensitizing effects on contractility. 38, 39 These mutants would also be worth investigating structurally.
Role of the C Terminus of cTnI in Heart Function
Although difficult to extrapolate complex functional sequelae from static structures, the conformation of tropomyosin conferred by the mutant troponin suggests possible mechanisms by which deletion of the C terminus of cTnI might influence heart function. The exposure of myosin-binding sites on actin is a key determinant of the rate of crossbridge attachment (so-called f app in the nomenclature of 2-state crossbridge models). 43 Our results with the mutant troponin would therefore favor a higher rate of crossbridge attachment at any given Ca 2ϩ concentration, which is consistent with recent work on stunned rat myocardium. 44 However, work with both models of stunned myocardium, and the mutant troponin in rat trabeculae, shows that force production is substantially compromised 11, 36, 44, 45 and at a higher energetic cost. 36, 44 This is indicative of increased crossbridge turnover that stems from an offsetting increase in the rate of crossbridge detachment (g app ). 44, 45 It is possible that destabilization of tropomyosin from the C-state toward the M-state by the mutant may decrease an energetic barrier to crossbridge detachment. Finally, functional studies of the mutant troponin have shown lower cooperativity of Ca 2ϩ -activated force production in rat trabeculae, 36 human cardiomyocytes, 46 and in a transgenic mouse model of myocardial stunning. 11 We submit that stunning characterized by low levels of cTnI truncation could well cause destabilization of tropomyosin as seen here, and thereby dampen propagation of Ca 2ϩ activation along the thin filament.
Indeed, previous work in a transgenic mouse model of stunning indicates that systolic and diastolic heart function is compromised when only 9% to 17% of the troponins contain truncated cTnI. 11 Destabilization of tropomyosin position would be expected to have large functional consequences in muscle, even with such low levels of cTnI proteolysis. Given the semirigid nature of tropomyosin, local destabilization would be propagated beyond a single troponin-tropomyosin regulatory unit. In other words, because thin filament regulatory switching is cooperative, an effect at one site, in this case because of mutant cTnI, will have a delocalized effect on neighboring sites even if those sites contain wild-type troponin.
Summary
In conclusion, a key issue regarding thin filament activation in striated muscle is: what are the precise molecular determinants that govern the movement of tropomyosin on actin, namely, what protein interactions influence its equilibrium position in the presence and absence of Ca 2ϩ ? Increased Ca 2ϩ sensitivity observed in studies of cTnI involves both higher affinity of Ca 2ϩ for troponin 36 and alteration of tropomyosin conformation on actin. This change in conformation reveals that cTnI actively stabilizes the natural C-state tropomyosin position in the presence of Ca 2ϩ . In diastole, residues 128 to 192 of cTnI are sufficient to generate the B-state, whereas determinants within the last 17 amino acids are critical to the C-state in systole. This work informs our understanding of myocardial stunning models characterized by cTnI proteolysis at the C terminus and suggests a framework for the consideration of restrictive and/or hypertrophic cardiomyopathy mutations within the same domain.
